MacroGenics Gets Nod For Margenza In HER2-Positive Breast Cancer

Company Reaches Milestone With First FDA Approval

 
• By Alaric DeArment
Doctor with Mammography - Image
MacroGenics won its first FDA approval, for Margenza in HER2-positive breast cancer • Source: Shutterstock

More from New Products

More from Scrip